These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3262384

  • 1. T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.
    Casellas P, Ravel S, Bourrié BJ, Derocq JM, Jansen FK, Laurent G, Gros P.
    Blood; 1988 Oct; 72(4):1197-202. PubMed ID: 3262384
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity of fresh leukemic cells to T101 ricin A-chain immunotoxin: a comparative study between Fab fragment and whole Ig conjugates.
    Chiron M, Derocq JM, Kuhlein E, Roubinet F, Demur C, Grandjean H, Huguet F, Jaffrezou JP, Jansen F, Laurent G.
    Leuk Res; 1989 Oct; 13(6):491-9. PubMed ID: 2788783
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
    Derocq JM, Casellas P, Laurent G, Ravel S, Vidal H, Jansen F.
    J Immunol; 1988 Oct 15; 141(8):2837-43. PubMed ID: 3262669
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bregni M, Bonnadonna G, Gianni AM.
    Blood; 1987 Jan 15; 69(1):345-8. PubMed ID: 3098324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
    Douay L, Gorin NC, Lopez M, Casellas P, Liance MC, Jansen FK, Voisin GA, Baillou C, Laporte JP, Najman A.
    Cancer Res; 1985 Jan 15; 45(1):438-41. PubMed ID: 3880666
    [Abstract] [Full Text] [Related]

  • 9. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.
    Leonard JE, Taetle R, To D, Rhyner K.
    Blood; 1985 May 15; 65(5):1149-57. PubMed ID: 3888307
    [Abstract] [Full Text] [Related]

  • 10. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
    Preijers FW, De Witte T, Wessels JM, De Gast GC, Van Leeuwen E, Capel PJ, Haanen C.
    Blood; 1989 Aug 15; 74(3):1152-8. PubMed ID: 2473811
    [Abstract] [Full Text] [Related]

  • 11. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M, Schlick E, Waldmann TA, Vitetta ES, Greene WC.
    Cancer Res; 1986 Jul 15; 46(7):3295-8. PubMed ID: 3011246
    [Abstract] [Full Text] [Related]

  • 12. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
    Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA.
    Blood; 1985 Sep 15; 66(3):627-35. PubMed ID: 3896347
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE, Wang QC, Kaplan NO, Royston I.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP, Levade T, Thurneyssen O, Chiron M, Bordier C, Attal M, Chatelain P, Laurent G.
    Cancer Res; 1992 Mar 01; 52(5):1352-9. PubMed ID: 1737397
    [Abstract] [Full Text] [Related]

  • 15. Different susceptibilities of normal T cells and T cell lines to immunotoxins.
    Preijers FW, Tax WJ, Wessels JM, Capel PJ, De Witte T, Haanen C.
    Scand J Immunol; 1988 May 01; 27(5):533-40. PubMed ID: 3259720
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
    Collinson AR, Lambert JM, Liu Y, O'Dea C, Shah SA, Rasmussen RA, Goldmacher VS.
    Int J Immunopharmacol; 1994 Jan 01; 16(1):37-49. PubMed ID: 8150554
    [Abstract] [Full Text] [Related]

  • 18. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
    Ravel S, Casellas P.
    Eur J Biochem; 1990 Sep 11; 192(2):469-73. PubMed ID: 2209602
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
    Jaffrézou JP, Levade T, Kuhlein E, Thurneyssen O, Chiron M, Grandjean H, Carrière D, Laurent G.
    Cancer Res; 1990 Sep 01; 50(17):5558-66. PubMed ID: 2386962
    [Abstract] [Full Text] [Related]

  • 20. An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin.
    Hertler AA, Schlossman DM, Borowitz MJ, Blythman HE, Casellas P, Frankel AE.
    Int J Cancer; 1989 Feb 15; 43(2):215-9. PubMed ID: 2465276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.